TGFB1 and breast carcinoma: Protection from CTL-mediated lysis has been reported to be associated with breast cancer cells undergoing EMT, wherein silencing of the WNT pathway coincides with hyperactivity of TGF-β signaling, EMT and acquisition of stemness properties [45].